1. AB0251 Early Onset of Benefit by Patient-Reported Outcomes (PROs) with Sarilumab Treatment in RA. (15th July 2016) Authors: Strand, V.; Chen, C.; Mahajan, P.; Kosinski, M.; Mangan, E.K.; van Hoogstraten, H.; Graham, N.; Lin, Y.; Keystone, E.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0252 Benefit of Sarilumab with csDMARDs on Patient Productivity in Work, Household Work and Family, Social, Leisure Activities in TNF-IR RA Patients. (15th July 2016) Authors: Strand, V.; Mahajan, P.; Chen, C.; van Hoogstraten, H.; Mangan, E.K.; Hagino, O.; Graham, N.; Pinheiro, G.da R.C.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0321 Predicting the Need for Rescue Medication Using Baseline Variables: Evidence from Rheumatoid Arthritis (RA) Patients in the Sarilumab Mobility Phase 3 Trial. (9th June 2015) Authors: Strand, V.; Rendas-Baum, R.; Chen, C.; Joseph, G.; Graham, N.; Van Hoogstraten, H.; Genovese, M.C.; Huizenga, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An innovative antimicrobial stewardship programme for children in remote and regional areas in Queensland, Australia: optimising antibiotic use through timely intravenous-to-oral switch. (March 2022) Authors: Avent, M.L.; Lee, X.J.; Irwin, A.D.; Graham, N.; Brain, D.; Fejzic, J.; van Driel, M.; Clark, J.E. Journal: Journal of global antimicrobial resistance Issue: Volume 28(2022) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials. (7th September 2020) Authors: Beck, L.A.; Silverberg, J.I.; Simpson, E.L.; Yosipovitch, G.; Eckert, L.; Guillemin, I.; Chen, Z.; Ardeleanu, M.; Plaum, S.; Graham, N.; Ruddy, M.; Pirozzi, G.; Gadkari, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exercise for mechanical neck disorders: a cochrane systematic review update. (May 2015) Authors: Gross, A.R.; Paquin, J.-P.; Blanchette, S.; Lalonde, P.; Christie, T.; Dupont, G.; Kay, T.; Graham, N.; Burnie, S.J.; Gelley, G.; Goldsmith, C.H.; Forget, M.; Hoving, J.L.; Brønfort, G.; Santaguida, P.L. Journal: Physiotherapy Issue: Volume 101(2016)Supplement 1 Page Start: e486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exercises for mechanical neck disorders: A Cochrane review update. (August 2016) Authors: Gross, A.R.; Paquin, J.P.; Dupont, G.; Blanchette, S.; Lalonde, P.; Cristie, T.; Graham, N.; Kay, T.M.; Burnie, S.J.; Gelley, G.; Goldsmith, C.H.; Forget, M.; Santaguida, P.L.; Yee, A.J.; Radisic, G.G.; Hoving, J.L.; Bronfort, G. Journal: Manual therapy Issue: Volume 24(2016:Aug.) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0020 Preclinical development of sarilumab, the first fully human monoclonal antibody (MAB) against IL-6r alpha: utilization and value of double humanized animal model. (23rd January 2014) Authors: Wang, L.-H.; Xue, Y.; Liu, X.; Luo, F.; Kelly, L.; Huang, T.; Valenzuela, D.; Papdopoulos, N.; Graham, N.; Murphy, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0058 Improvements in Health Related Quality of Life (HRQOL) Reported by Rheumatoid Arthritis (RA) Patients in a Randomized Controlled Trial [RCT] of Sarilumab [Mobility] that Met or Exceeded the Patient Acceptable Symptom State [Pass] And Normative Values. (9th June 2015) Authors: Strand, V.; Kosinski, M.; Joseph, G.; Chen, C.; Van Hoogstraten, H.; Graham, N.; Huizenga, T.; Genovese, M.C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients. (15th July 2016) Authors: Genovese, M.C.; Fay, J.; Parrino, J.; Garg, A.; van Hoogstraten, H.; Boddy, A.; Martincova, R.; Graham, N.; Simon, J.; Burmester, G.R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗